Bumetanide, a new potent diuretic. A clinical evaluation in congestive heart failure.
D000136:Acid-Base Equilibrium / Q000187:drug effects*; D000284:Administration, Oral; D000410:Alanine Transaminase / Q000097:blood; D001565:Benzoates / Q000008:administration & dosage / Q000627:therapeutic use; D001663:Bilirubin / Q000097:blood; D001798:Blood Proteins / Q000032:analysis; D001835:Body Weight; D002082:Butylamines / Q000008:administration & dosage / Q000627:therapeutic use; D002712:Chlorides / Q000652:urine; D002986:Clinical Trials as Topic; D003404:Creatinine / Q000097:blood; D004231:Diuresis / Q000187:drug effects*; D004232:Diuretics / Q000008:administration & dosage / Q000627:therapeutic use*; D005665:Furosemide / Q000627:therapeutic use; D006333:Heart Failure / Q000188:drug therapy*; D006454:Hemoglobins / Q000032:analysis; D006801:Humans; D009318:Natriuresis / Q000187:drug effects*; D010636:Phenols / Q000008:administration & dosage / Q000627:therapeutic use*; D010919:Placebos; D011188:Potassium / Q000652:urine; D013449:Sulfonamides / Q000008:administration & dosage / Q000627:therapeutic use*; D014882:Water-Electrolyte Balance / Q000187:drug effects*
D001565:Benzoates; D001798:Blood Proteins; D002082:Butylamines; D002712:Chlorides; D004232:Diuretics; D006454:Hemoglobins; D010636:Phenols; D010919:Placebos; D013449:Sulfonamides; D005665:Furosemide; D003404:Creatinine; D000410:Alanine Transaminase; D001663:Bilirubin; D011188:Potassium